Home/Pipeline/Phoenix CR

Phoenix CR

Post-Traumatic Stress Disorder (PTSD)

UnknownActive

Key Facts

Indication

Post-Traumatic Stress Disorder (PTSD)

Phase

Unknown

Status

Active

Company

Evren Technologies

About Evren Technologies

Evren Technologies is a private, pre-revenue digital health company founded in 2021, pioneering non-invasive bioelectronic therapies for PTSD. Its core technology is the Phoenix CR, a portable taVNS device designed to deliver electrical stimulation to the vagus nerve via the ear, aiming to restore autonomic balance and alleviate PTSD symptoms. The company is currently seeking investment to fund the final stages of FDA clinical trials and go-to-market activities, targeting a significant and underserved mental health market.

View full company profile

Therapeutic Areas

Psychiatry Neurology

Other Post-Traumatic Stress Disorder (PTSD) Drugs

Drug	Company	Phase	Status
AL001	Alzamend Neuro	Preclinical	Research
PES200	Virpax Pharmaceuticals	Discovery/Preclinical	Active
Sequential Dialysis Technique	Halberd	Discovery	Active Research (Gov't Funding Sought)
NeuroDirect™ Ketamine	Psycheceutical Bioscience	Phase 1	Active
Sana Device for PTSD	Sana Health	Pilot/Proof-of-Concept	Active
MDMA-assisted therapy	Lykos Therapeutics	Phase 3	Active
Neuroplastogen Programs	Delix Therapeutics	Pre-clinical	Active
TSND-201 (Methylone)	Transcend Therapeutics	Phase 2	Active
Lu AG09222	Lundbeck	Phase 2	Active
COMP360 Psilocybin Therapy	Compass Pathways	Phase 2	Active
NRX-101	NRx Pharmaceuticals	Phase 2	Investigational
Ketamir-2 (Ketamir)	MIRA Pharmaceuticals	Phase 1	Active